169 related articles for article (PubMed ID: 1721315)
21. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
[No Abstract] [Full Text] [Related]
22. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
23. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A
Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317
[No Abstract] [Full Text] [Related]
24. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
[No Abstract] [Full Text] [Related]
25. Augmentation of T-cell apoptosis by immunosuppressive agents.
Takahashi K; Reynolds M; Ogawa N; Longo DL; Burdick J
Clin Transplant; 2004; 18 Suppl 12():72-5. PubMed ID: 15217412
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis.
Staruch MJ; Sigal NH; Dumont FJ
Int J Immunopharmacol; 1991; 13(6):677-85. PubMed ID: 1721613
[TBL] [Abstract][Full Text] [Related]
27. Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner.
Su MS; Semerjian A
Transplant Proc; 1991 Dec; 23(6):2912-5. PubMed ID: 1721310
[No Abstract] [Full Text] [Related]
28. The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
Weaver JL; Pine PS; Aszalos A
Immunopharmacol Immunotoxicol; 1994 May; 16(2):179-90. PubMed ID: 7521360
[TBL] [Abstract][Full Text] [Related]
29. FK-506--a novel immunosuppressant.
Parsons WH; Sigal NH; Wyvratt MJ
Ann N Y Acad Sci; 1993 Jun; 685():22-36. PubMed ID: 7689805
[No Abstract] [Full Text] [Related]
30. Assessment of immunosuppression by lymphocyte functions in human blood.
Barten MJ; Rahmel A; Chang H; Tarnok A; Gehlhaar P; Dhein S; Gummert JF
Transplant Proc; 2002 Nov; 34(7):2876-7. PubMed ID: 12431640
[No Abstract] [Full Text] [Related]
31. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
Duncan JI
J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
[TBL] [Abstract][Full Text] [Related]
32. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466
[No Abstract] [Full Text] [Related]
33. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
Morris RE
Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
[No Abstract] [Full Text] [Related]
34. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.
Sigal NH; Lin CS; Siekierka JJ
Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132
[No Abstract] [Full Text] [Related]
35. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
Hultsch T; Hohman RJ
Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
[No Abstract] [Full Text] [Related]
36. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
[No Abstract] [Full Text] [Related]
37. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
[No Abstract] [Full Text] [Related]
38. Analysis of biochemical and biological functions of Fas-ligand (FasL) and Fas on activated T cells in allo-immune response.
Nakajima H; Oka T
Transplant Proc; 1997; 29(1-2):1096-100. PubMed ID: 9123217
[No Abstract] [Full Text] [Related]
39. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
Pockley AG; Williams S; Reid SD; Bowles MJ
Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800
[No Abstract] [Full Text] [Related]
40. Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
Kyles AE; Gregory CR; Craigmill AL
Am J Vet Res; 2000 Aug; 61(8):906-9. PubMed ID: 10951980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
